Health Canada Authorizes Dexcom G7 15 Day CGM for Adults with Diabetes

Product / Tech
โดย Business Wire·Read original
Summary · why it matters

Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for people 18 years and older living with diabetes. The system is the longest-lasting and most accurate CGM authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days. It features best-in-class accuracy with an overall MARD of 8.0% and requires fewer sensor changes per month. The device is not yet available for purchase, with Dexcom Canada focusing on ensuring support and education are in place before launch.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
DexCom Inc
DXCM
▲ PositiveTechnologyrelevance

Health Canada authorized Dexcom G7 15 Day CGM, a new product with longer wear and best-in-class accuracy.